Shares of Elevance Health, Inc. ( NYSE:ELV – Get Free Report ) have been assigned an average recommendation of 'Moderate Buy' from the thirteen analysts that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $568.46. ELV has been the topic of a number of research analyst reports.

https://www.dailypolitical.com/2023/09/10/analysts-set-elevance-health-inc-nyseelv-target-price-at-568-93.html

#dailypolitical